Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Kane Biotech Inc V.KNE

Alternate Symbol(s):  KNBIF

Healthcare Biotechnology
Kane Biotech Inc. is a Canada-based biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Company has a portfolio of biotechnologies, intellectual property (66 patents and patents pending, trade secrets and trademarks) and products developed by its own biofilm research expertise and acquired... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (TSXV:KNE)

Kane Biotech to Release Third Quarter 2024 Financial Results on November 28, 2024

GlobeNewswire 20 hours ago

Kane Biotech Announces Health Canada Approval of revyve(TM) Antimicrobial Wound Gel

GlobeNewswire 8 days ago

Kane Biotech Provides Investor Update Following FB Dermatology Acquisition Announcement

GlobeNewswire 8 days ago

Canadian Investment Regulatory Organization Trade Resumption - KNE

Canada NewsWire 9 days ago

Kane Biotech Announces Agreement to Acquire FB Dermatology

GlobeNewswire 10 days ago

Canadian Investment Regulatory Organization Trading Halt - KNE

Canada NewsWire 10 days ago

Kane Biotech Announces Donation of revyve(TM) Antimicrobial Wound Gel to Ukraine

GlobeNewswire October 23, 2024

Kane Biotech Announces Exclusive Distribution Agreement With XSONX

GlobeNewswire October 17, 2024

Kane Biotech to Participate in a Multinational Corporate Collaboration Project

GlobeNewswire October 3, 2024
View More News ››

Opinion & Analysis (TSXV:KNE)

Emerging opportunity in a growing, high-value dermatological market

Ryan Dhillon April 11, 2024

Big Copper Fox Metals’ (V.CUU) shareholders under water?

Stockhouse Editorial September 17, 2014

John Kaiser: ‘The bull is back,’ Stockhouse poster says

Stockhouse Editorial February 5, 2014
View More Opinion ››

Bullboard Posts (TSXV:KNE)

RE:RE:RE:RE:RE:RE:RE:RE:New Press Release - Kane Biotech Announces Health Canada Approval of revyve(TM)&#xA0;Antimicrobial Wound Gel

You'll probably see the spray listed here before it gets delivered to Progena.  https://www.progenacare.com/products/
KevinOleary - 2 days ago

RE:RE:RE:RE:RE:RE:RE:New Press Release - Kane Biotech Announces Health Canada Approval of revyve(TM)&#xA0;Antimicrobial Wound Gel

Yes francois, the holdup in getting to market after the FDA approved the dosage was scheduling with Halo, then shipping to Sweden for...
KevinOleary - 6 days ago

RE:New Press Release - Kane Biotech Announces Health Canada Approval of revyve(TM)&#xA0;Antimicrobial Wound Gel

This is an important milestone that allows a launch of a new product to Canadian consumers and a chance to demonstrate a working model...
MirrorWorldMan - 6 days ago

RE:RE:RE:RE:RE:RE:New Press Release - Kane Biotech Announces Health Canada Approval of revyve(TM)&#xA0;Antimicrobial Wound Gel

Good piece of info KevinOleary...so, in short, the FDA released mention back in January was basically push aside when the higher dosage...
francoisl13 - 7 days ago

RE:RE:RE:RE:RE:New Press Release - Kane Biotech Announces Health Canada Approval of revyve(TM)&#xA0;Antimicrobial Wound Gel

2. The spray does not contact the propellant, so no new permission is needed for its use. They don't need any more FDA permission...
KevinOleary - 7 days ago

RE:RE:RE:RE:New Press Release - Kane Biotech Announces Health Canada Approval of revyve(TM)&#xA0;Antimicrobial Wound Gel

This is (2) excerpts from Kane's press release from last January regarding the 'wound gel spray' product; ''Kane...
francoisl13 - 7 days ago
View more Bullboard ››

GameSquare Holdings Inc.

GameSquare Holdings Inc.

GameSquare Holdings, Inc. is a vertically integrated, digital media, entertainment and technology company. It connects global ...
View More »